Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Sales | 200,372 | 238,870 | 165,105 | 145,027 | 133,984 |
| Cost of Goods | 25,936 | 32,106 | 21,372 | 19,552 | 20,412 |
| Gross Profit | 174,436 | 206,764 | 143,733 | 125,475 | 113,572 |
| Operating Expenses | 96,199 | 99,098 | 577,702 | 93,188 | 78,067 |
| Operating Income | 79,173 | 107,772 | -433,597 | 32,839 | 35,917 |
| Interest Expense | 5,538 | 5,569 | 5,614 | 3,471 | 3,445 |
| Other Income | 3,316 | 3,444 | 3,817 | 7,187 | -11,165 |
| Pre-tax Income | 76,951 | 105,647 | -435,394 | 36,555 | 21,307 |
| Income Tax | 3,855 | 5,275 | 2,660 | 1,076 | 550 |
| Net Income Continuous | 73,096 | 100,372 | -438,054 | 35,479 | 20,757 |
| Net Income | $73,096 | $100,372 | $-438,054 | $35,479 | $20,757 |
| EPS Basic Total Ops | 0.05 | 0.06 | -0.28 | 0.02 | 0.01 |
| EPS Basic Continuous Ops | 0.05 | 0.06 | -0.28 | 0.02 | 0.01 |
| EPS Diluted Total Ops | 0.04 | 0.06 | -0.28 | 0.02 | 0.01 |
| EPS Diluted Continuous Ops | 0.04 | 0.05 | -0.28 | 0.02 | 0.01 |
| EBITDA(a) | $84,325 | $112,723 | $-428,998 | $36,728 | $39,665 |